Profusa, Inc. has filed a preliminary proxy statement as it prepares for a special meeting of stockholders scheduled for December 11, 2026. This meeting will focus on crucial proposals that could significantly impact the company's financial structure and shareholder value.
The special meeting will be held virtually at 10:00 a.m. Eastern Time. Stockholders can participate by visiting the designated website and entering their control numbers. The primary agenda includes three key proposals: a stock issuance proposal, a reverse stock split proposal, and an adjournment proposal.
The stock issuance proposal seeks approval for the issuance of shares representing more than 19.99% of the company's outstanding common stock. This move is intended to comply with Nasdaq Listing Rule 5635(d) and is part of a broader strategy related to the company's debt reorganization.
The reverse stock split proposal aims to amend the company's certificate of incorporation to allow for one or more reverse stock splits at the discretion of the board of directors, with a potential range of 1-for-2 to 1-for-200. This could help manage the company’s share price and improve its market perception.
Lastly, the adjournment proposal would enable the company to postpone the meeting if necessary to gather more votes for the other proposals. This flexibility is crucial for ensuring that the company can secure the necessary approvals.
Profusa, Inc. operates in the surgical and medical instruments and apparatus sector, as indicated by its SIC code 3841. The company is listed on the Nasdaq under the ticker PFSA and also trades on the OTC market under NVACW. This filing, accession number 0001213900-26-118062, underscores the company's ongoing efforts to navigate its financial landscape and engage with its shareholders effectively.
As the industry continues to evolve, the outcomes of these proposals may set a precedent for other companies within the surgical and medical instruments sector, particularly in how they approach capital management and shareholder engagement.
What happens next will depend on the outcomes of the special meeting and the subsequent votes from stockholders.
Read Next
Cadence Design Systems Director Chew Lewis Files to Sell Shares
Veea Inc. Files Proxy Statement for Annual Meeting
Chemomab Therapeutics files proxy for merger with Scipher
Iron Horse Acquisition II Corp. Updates Merger Plans with Electra
DoubleU Games launches tender offer for DoubleDown Interactive
T3 Defense to Hold Special Meeting for Key Proposals










